| Guy Rozen, MD | |
|
50 Rowe St Ste 500, Melrose, MA 02176-3201 | |
| (781) 979-3800 | |
| (781) 662-2778 |
| Full Name | Guy Rozen |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 17 Years |
| Location | 50 Rowe St Ste 500, Melrose, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871903377 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tufts Medical Center | Boston, MA | Hospital |
| Melrosewakefield Healthcare | Melrose, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cardiovascular Center At Tufts Medical Center Inc | 3870857816 | 96 |
| Melrose Internal Medicine Assoc Pc | 6901984897 | 3 |
News Archive
Analysis of the largest American cancer database indicates that racial disparities persist in the treatment and outcomes of patients diagnosed with stage I non-small cell lung cancer (NSCLC).
Aduro BioTech, Inc., a clinical stage biotechnology company, today announced the presentation of safety and efficacy data from a Phase 1b clinical trial of its novel immunotherapy CRS-207 in combination with standard chemotherapy in patients with unresectable malignant pleural mesothelioma.
Patients with hypertension and certain gene variations experienced varying results with some blood pressure medications, suggesting matching a patient's genotype with certain hypertension medications could result in more favorable outcomes, according to a study in the January 23 issue of JAMA: The Journal of the American Medical Association.
A new study suggests that a genetic fingerprint associated with normal embryonic stem cells may be important for the development and function of cancer stem cells.
› Verified 6 days ago
| Entity Name | Melrose Internal Medicine Assoc Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629055538 PECOS PAC ID: 6901984897 Enrollment ID: O20080417000172 |
News Archive
Analysis of the largest American cancer database indicates that racial disparities persist in the treatment and outcomes of patients diagnosed with stage I non-small cell lung cancer (NSCLC).
Aduro BioTech, Inc., a clinical stage biotechnology company, today announced the presentation of safety and efficacy data from a Phase 1b clinical trial of its novel immunotherapy CRS-207 in combination with standard chemotherapy in patients with unresectable malignant pleural mesothelioma.
Patients with hypertension and certain gene variations experienced varying results with some blood pressure medications, suggesting matching a patient's genotype with certain hypertension medications could result in more favorable outcomes, according to a study in the January 23 issue of JAMA: The Journal of the American Medical Association.
A new study suggests that a genetic fingerprint associated with normal embryonic stem cells may be important for the development and function of cancer stem cells.
› Verified 6 days ago
| Entity Name | Cardiovascular Center At Tufts Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447764253 PECOS PAC ID: 3870857816 Enrollment ID: O20180430000179 |
News Archive
Analysis of the largest American cancer database indicates that racial disparities persist in the treatment and outcomes of patients diagnosed with stage I non-small cell lung cancer (NSCLC).
Aduro BioTech, Inc., a clinical stage biotechnology company, today announced the presentation of safety and efficacy data from a Phase 1b clinical trial of its novel immunotherapy CRS-207 in combination with standard chemotherapy in patients with unresectable malignant pleural mesothelioma.
Patients with hypertension and certain gene variations experienced varying results with some blood pressure medications, suggesting matching a patient's genotype with certain hypertension medications could result in more favorable outcomes, according to a study in the January 23 issue of JAMA: The Journal of the American Medical Association.
A new study suggests that a genetic fingerprint associated with normal embryonic stem cells may be important for the development and function of cancer stem cells.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Guy Rozen, MD 50 Rowe St Ste 500, Melrose, MA 02176-3201 Ph: (781) 979-3800 | Guy Rozen, MD 50 Rowe St Ste 500, Melrose, MA 02176-3201 Ph: (781) 979-3800 |
News Archive
Analysis of the largest American cancer database indicates that racial disparities persist in the treatment and outcomes of patients diagnosed with stage I non-small cell lung cancer (NSCLC).
Aduro BioTech, Inc., a clinical stage biotechnology company, today announced the presentation of safety and efficacy data from a Phase 1b clinical trial of its novel immunotherapy CRS-207 in combination with standard chemotherapy in patients with unresectable malignant pleural mesothelioma.
Patients with hypertension and certain gene variations experienced varying results with some blood pressure medications, suggesting matching a patient's genotype with certain hypertension medications could result in more favorable outcomes, according to a study in the January 23 issue of JAMA: The Journal of the American Medical Association.
A new study suggests that a genetic fingerprint associated with normal embryonic stem cells may be important for the development and function of cancer stem cells.
› Verified 6 days ago
Fadel Bofarrag, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 585 Lebanon St, Melrose, MA 02176 Phone: 800-424-3672 Fax: 314-434-5939 | |
Prava Karki, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 585 Lebanon St, Melrose, MA 02176 Phone: 781-979-3000 | |
Mike H Summerer, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 585 Lebanon Street, Hallmark Health System, Melrose, MA 02176 Phone: 781-979-3342 | |
Mohender S Maan, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 585 Lebanon St, Melrose Wakefield Hospital, Melrose, MA 02176 Phone: 781-979-3000 | |
Dr. Erica L Brooks, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 50 Rowe St, Suite 600, Melrose, MA 02176 Phone: 781-979-3440 Fax: 781-979-0258 | |
Dr. Raj P. Shah, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 585 Lebanon St, Melrose, MA 02176 Phone: 860-305-6911 | |
Ronald P Sen, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 50 Tremont St, #109, Melrose, MA 02176 Phone: 781-662-3310 Fax: 781-662-6403 |